Project Grant R00DE032747
- Summary of Federal Project Grant Award The National Institute of Dental and Craniofacial Research (NIDCR) awarded $320,660 to the University of Illinois (Chicago) under the Oral Diseases and Disorders Research program (CFDA 93.121) on April 6, 2026, to support research investigating the immunoregulatory role of dendritic cell (DC) subsets in periodontal disease. The research focuses on elucidating how three major DC subsets—myeloid DC (MDC), lymphoid DC (LDC), and plasmacytoid DC...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded University of California, Los Angeles $180,943.00 under the Oral Diseases and Disorders Research program (CFDA 93.121) on June 13, 2025, for research addressing therapeutic targeting of apical periodontal T-cells in chronic oral inflammation. The research initiative, which extends through May 31, 2030, investigates the pathogenic mechanisms underlying apical periodontitis—a chronic...
- This $101,828 Project Grant, awarded December 1, 2026, by the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research conducted by Virginia Commonwealth University to characterize phospholipase A2 (PLA2) enzyme function and structure in Porphyromonas gingivalis, a keystone pathogen in periodontal disease. The research addresses a gap in understanding the pathogenic mechanisms linking elevated PLA activity in...
- This Project Grant award of $770,578, obligated on August 22, 2025, supports basic and translational research on senescent periodontal ligament cells as a therapeutic target for age-associated periodontitis through the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The research, conducted by Augusta University Research Institute, Inc. in Augusta, Georgia through May 31, 2030, investigates the mechanisms by...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University a $568,759 Project Grant (CFDA 93.121: Oral Diseases and Disorders Research) effective May 1, 2026, through April 30, 2031, to conduct basic research on pathogen synergy and immune subversion in periodontal disease. The research deliverables include scientific investigations of how two gram-negative anaerobic...
- This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
- Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded University of Massachusetts Lowell $100,676 under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop a three-dimensional (3D) in vitro human periodontal sulcus tissue model for studying early biomarkers of oral dysbiosis. The award, obligated on September 30, 2026, with an ultimate completion date of April 14, 2027, funds research to create an advanced tissue culture system...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $446,875 to support research on the role of a novel G protein-coupled receptor, MRGPRX2, in the development of periodontal disease. The funded research aims to develop two humanized mouse models to study the contribution of MRGPRX2-expressing mast cells to Porphyromonas gingivalis-induced and ligature-induced...
- Summary Cedars-Sinai Medical Center received a $2.39 million Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded August 15, 2025, with completion targeted for May 31, 2030. The grant supports development of bioengineered, vascularized oral mucosal grafts derived from induced pluripotent stem cells (iPSCs) to address the clinical need for improved soft tissue grafting solutions. Over...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $423,500.00 to Nova Southeastern University, Inc. to develop a humanized mouse model of periodontitis. The goal is to investigate the potential pathogenic role of the protein Semaphorin 4D expressed by human osteoclasts in the progression of periodontal disease. This advanced mouse model will allow researchers to...
T CELL RESPONSE IN AGGREGATIBACTER ACTINOMYCETEMCOMITANS-ASSOCIATED PERIODONTAL DISEASE - PROJECT SUMMARY/ABSTRACT PERIODONTITIS (PD) IS ONE OF THE MOST COMMON INFLAMMATORY DISEASES, AFFECTS HUNDREDS OF MILLIONS OF PEOPLE WORLDWIDE, AND POSES A SIGNIFICANT GLOBAL ECONOMIC BURDEN. SEVERE PD LEADS TO ORAL MUCOSAL INFLAMMATION, DESTRUCTION OF TOOTH-SUPPORTING BONE AND TOOTH LOSS. AGGREGATIBACTER ACTINOMYCETEMCOMITANS (AA) IS AN ORAL MICROBE THAT IS ASSOCIATED WITH SEVERE DISEASE, YET, HOW T CELL RECOGNITION AND THE ENSUING IMMUNE RESPONSE TO AA CONTRIBUTES TO IMMUNOPATHOLOGY IS NOT WELL UNDERSTOOD. THUS, THIS PROPOSAL WILL EXPLORE THE CENTRAL HYPOTHESIS THAT AA-SPECIFIC T CELL RESPONSES CONTRIBUTE TO TISSUE DESTRUCTION IN AA-ASSOCIATED PERIODONTITIS. IN AIM 1, SYSTEMIC T CELL RESPONSE TO AA IN HUMAN PD WILL BE ASSESSED. BIOBANKED PATIENT PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) WILL BE CO-CULTURED WITH HEAT-KILLED AA. T CELLS WILL BE ISOLATED AND ASSESSED BY FLOW CYTOMETRY AND SINGLE CELL RNA SEQUENCING. IN AIM 2, THE ROLE OF AA-SPECIFIC T CELLS IN PERIODONTAL IMMUNOPATHOLOGY WILL BE DETERMINED. T CELLS THAT RESPOND TO AA ANTIGEN WILL BE USED TO GENERATE RETROGENIC T CELL RECEPTOR (RGTCR) MICE THAT PRODUCE T CELLS SPECIFIC TO AA ANTIGEN. AA-SPECIFIC T CELLS WILL BE TRANSFERRED TO MICE FOLLOWED BY INDUCTION OF AA-ASSOCIATED EXPERIMENTAL PERIODONTITIS. IMMUNE RESPONSE AND PATHOLOGY WILL BE ASSESSED USING BONE LOSS MEASUREMENT, ITERATIVE IMMUNOSTAINING, FLOW CYTOMETRY, AND SINGLE CELL RNA SEQUENCING. SUCCESSFUL COMPLETION OF THESE AIMS WILL BEGIN TO UNCOVER THE ROLE OF ADAPTIVE IMMUNE RESPONSE IN ORAL DISEASE AND MAY PAVE THE WAY FOR PRECISE THERAPEUTIC INTERVENTIONS FOR PD. THE PROPOSED EXPERIMENTS WILL PROVIDE ME WITH TRAINING IN NEW METHODOLOGIES (HUMAN AND MOUSE T CELL CULTURE, ITERATIVE IMMUNOSTAINING, ADOPTIVE CELL TRANSFER) AND CONCEPTS (HOST-MICROBE INTERACTIONS, T CELL BIOLOGY), WHICH WILL SERVE AS A CRITICAL FOUNDATION TO MY INDEPENDENT RESEARCH PROGRAM THAT WILL STUDY T CELL RESPONSE TO INDIGENOUS AND PATHOGENIC MICROBES AT THE ORAL BARRIER IN MICE AND HUMANS. THE MENTORED PHASE WILL OCCUR IN THE LABORATORIES OF MY PRIMARY MENTOR AND CO-MENTOR, DR.'S MOUTSOPOULOS AND BELKAID AT NIH, WHICH HAVE THE COMBINED EXPERTISE, EQUIPMENT AND FACILITIES NECESSARY TO CARRY OUT THE PROPOSED WORK. ADDITIONAL SCIENTIFIC, CAREER, AND TECHNICAL SUPPORT WILL BE PROVIDED BY A WELL-ROUNDED TEAM OF MENTOR-ADVISORS AND CONSULTANTS. I WILL MEET REGULARLY WITH MY TEAM TO RECEIVE FEEDBACK ON RESEARCH AND CAREER PROGRESS. I WILL ALSO COMPLETE ADDITIONAL TRAINING IN GRANT/MANUSCRIPT WRITING, LAB MANAGEMENT, MENTORSHIP, AND ACADEMIC JOB MARKET PREPARATION. THE PROPOSED TRAINING PLAN WILL PROVIDE NECESSARY SKILLS TO ESTABLISH AND LEAD A COMPETITIVE INDEPENDENT RESEARCH PROGRAM.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $245.5k | 12/5/25 | ||
| Not listed | $248.6k | 4/25/25 | ||
| Not listed | $248.6k | 4/25/25 |